InMed Pharmaceuticals Inc. (INM)
USD 4.35
(-14.71%)
USD 4.35
(-14.71%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 4.59 Million | 4.13 Million | 1.08 Million | - | - | - |
| Cost of Revenue | 6.99 Billion | 2.73 Million | 545.88 Thousand | 197.03 Thousand | 183.09 Thousand | 93.94 Thousand |
| Gross Profit | -6.98 Billion | 1.4 Million | 543.54 Thousand | -197.03 Thousand | -183.09 Thousand | -93.94 Thousand |
| Operating Expenses | 9.01 Billion | 9.78 Million | 14.33 Million | 9.93 Million | 8.86 Million | 10.39 Million |
| Selling, General and Administrative Expenses | 5.25 Billion | 5.84 Million | 6.86 Million | 4.47 Million | 3.5 Million | 6 Million |
| Research and Development Expenses | 3.76 Billion | 3.73 Million | 7.28 Million | 5.33 Million | 5.2 Million | 4.29 Million |
| Other Expenses | - | -308.94 Thousand | 185.65 Thousand | 120.86 Thousand | 161.96 Thousand | 94.71 Thousand |
| Cost and Expenses | 16 Billion | 12.51 Million | 14.88 Million | 9.93 Million | 8.86 Million | 10.39 Million |
| Operating Income | - | -8.17 Billion | -13.69 Million | -9.92 Million | -8.74 Million | -10.35 Million |
| Interest Expense | - | - | 96.09 Thousand | 360.35 Thousand | 18.61 Thousand | - |
| Income Tax Expense | 7100.00 | 13.1 Thousand | 4.8 Million | 360.35 Thousand | 18.61 Thousand | -262.1 Thousand |
| Earnings before Tax | -7.66 Million | -7.93 Million | -18.6 Million | -10.2 Million | -8.68 Million | -10.09 Million |
| Net Income | -7.67 Million | -7.94 Million | -18.6 Million | -10.2 Million | -8.94 Million | -10.01 Million |
| Earnings Per Share Basic | -1.01 | -3.25 | -33.17 | -37.78 | -42.57 | -47.67 |
| Earnings Per Share Diluted | -1.01 | -3.25 | -33.17 | -37.78 | -42.57 | -47.67 |
| Weighted Average Shares Outstanding | 7.58 Million | 2.44 Million | 560.75 Thousand | 270 Thousand | 210 Thousand | 210 Thousand |
| Weighted Average Shares Outstanding (Diluted) | 7.58 Million | 2.44 Million | 560.82 Thousand | 270 Thousand | 210 Thousand | 210 Thousand |
| Gross Margin | -1520.11 | 0.34 | 0.50 | - | - | - |
| EBIT Margin | -1.54 | -1.87 | -12.10 | - | - | - |
| Profit Margin | -1.67 | -1.92 | -17.07 | - | - | - |
| EBITDA | -7.06 Million | -10.83 Million | -17.25 Million | -9.8 Million | -8.58 Million | -10.26 Million |
| Earnings Before Tax Margin | - | -1977.13 | -12.57 | - | - | - |
| Breakdown | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 |
|---|---|---|---|---|---|---|
| Revenue | 8.09 Billion | 1.17 Million | 1.24 Million | 1.68 Million | 4.13 Million | 2.31 Million |
| Cost of Revenue | 6.99 Billion | 1.03 Million | 916.05 Thousand | 1.66 Million | 2.73 Million | 740.68 Thousand |
| Gross Profit | 1.1 Billion | 139.07 Thousand | 324.14 Thousand | 21.24 Thousand | 1.4 Million | 1.57 Million |
| Operating Expenses | 9 Billion | 1.93 Million | 2.02 Million | 2.59 Million | 9.78 Million | 2.08 Million |
| Selling, General and Administrative Expenses | 5.24 Billion | 1.27 Million | 1.36 Million | 1.29 Million | - | 1.4 Million |
| Research and Development Expenses | 3.76 Billion | 656.76 Thousand | 609.79 Thousand | 1.29 Million | - | 623.74 Thousand |
| Other Expenses | 263.39 Thousand | - | -170.46 Thousand | -92.93 Thousand | -308.94 Thousand | -148.78 Thousand |
| Cost and Expenses | 15.99 Billion | 2.96 Million | 2.94 Million | 4.25 Million | 12.51 Million | 2.82 Million |
| Operating Income | -6.26 Billion | -1.79 Million | -1.64 Billion | -2.56 Million | -8.17 Billion | -8.16 Billion |
| Interest Expense | - | - | - | - | - | 102.15 Million |
| Income Tax Expense | -6.88 Million | -3.00 | -226.65 Thousand | 11.55 Thousand | 13.1 Thousand | 1800.00 |
| Earnings before Tax | -7.66 Billion | -1.72 Million | -1.47 Million | -2.53 Million | -7.93 Million | -336.59 Thousand |
| Net Income | -7.65 Million | -1.72 Million | -1.47 Million | -2.53 Million | -7.94 Million | -338.39 Thousand |
| Earnings Per Share Basic | -1.00 | -0.18 | -0.19 | -0.76 | - | -0.10 |
| Earnings Per Share Diluted | -1.00 | -0.18 | -0.19 | -0.76 | - | -0.10 |
| Weighted Average Shares Outstanding | 7.65 Million | 9.61 Million | 7.97 Million | 3.32 Million | 2.44 Million | 3.32 Million |
| Weighted Average Shares Outstanding (Diluted) | 7.65 Million | 9.61 Million | 7.97 Million | 3.32 Million | 2.44 Million | 3.32 Million |
| Gross Margin | 0.14 | 0.12 | 0.26 | 0.01 | 0.34 | 0.68 |
| EBIT Margin | -0.92 | -1.40 | -1.30 | -1.49 | - | -0.17 |
| Profit Margin | -0.00 | -1.47 | -1.19 | -1.50 | -1.92 | -0.15 |
| EBITDA | -7.44 Billion | -1.64 Million | -1.61 Million | -2.51 Million | - | -396.4 Thousand |
| Earnings Before Tax Margin | -0.77 | -1.53 | -1330.11 | -1.52 | -1977.13 | -3534.63 |
AMZ
8038
KHNZ
ALCLS
DRNG
MTRE3